Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05109 (
S100A8
)
1,212
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The epidermal differentiation complex (EDC) is the most rapidly evolving locus in the human genome compared to that of the chimpanzee. Yet the EDC genes that are undergoing positive selection across mammals and in humans are not known. We sought to identify the positively selected genetic variants and determine the evolutionary events of the EDC using mammalian-wide and clade-specific branch- and branch-site likelihood ratio tests and a genetic algorithm (GA) branch test. Significant non-synonymous substitutions were found in
filaggrin,
SPRR4
, LELP1
, and
S100A2
genes across 14 mammals. By contrast, we identified recent positive selection in
SPRR4
in primates. Additionally, the GA branch test discovered lineage-specific evolution for distinct EDC genes occurring in each of the nodes in the 14-mammal phylogenetic tree. Multiple instances of positive selection for
FLG, TCHHL1,
SPRR4
, LELP1
, and
S100A2
were noted among the primate branch nodes. Branch-site likelihood ratio tests further revealed positive selection in specific sites in
SPRR4
, LELP1, filaggrin
, and
repetin
across 14 mammals. However, in addition to continuous evolution of
SPRR4
, site-specific positive selection was also found in
S100A11, KPRP, SPRR1A, S100A7L2
, and
S100A3
in primates and
filaggrin, filaggrin2
, and
S100A8
in great apes. Very recent human positive selection was identified in the
filaggrin2
L41 site that was present in Neanderthal. Together, our results identifying recent positive selection in distinct EDC genes reveal an underappreciated evolution of epidermal skin barrier function in primates and humans.
...
PMID:Recent Positive Selection in Genes of the Mammalian Epidermal Differentiation Complex Locus. 2811 36